1
|
Ota H, Danno K, Ohta K, Matsumura T, Komori T, Okamura S, Okano M, Ogawa A, Tamagawa H, Uemura M, Matsuda C, Mizushima T, Yamamoto H, Nezu R, Doki Y, Eguchi H. Efficacy of Negative Pressure Wound Therapy Followed by Delayed Primary Closure for Abdominal Wounds in Patients with Lower Gastrointestinal Perforations: Multicenter Prospective Study. JOURNAL OF THE ANUS RECTUM AND COLON 2020; 4:114-121. [PMID: 32743113 PMCID: PMC7390614 DOI: 10.23922/jarc.2019-043] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/24/2019] [Accepted: 03/24/2020] [Indexed: 11/30/2022]
Abstract
Objectives: The efficacy of negative pressure wound therapy (NPWT) and its application to severely contaminated wounds sustained during surgery remain to be established. Here, we evaluated the efficacy of utilizing NPWT until delayed primary closure (DPC) by assessing the infection rates in patients with lower gastrointestinal perforations. Methods: This prospective multicenter cohort study included 56 patients that underwent abdominal surgery for lower gastrointestinal perforations in eight institutions, from February 2016 to May 2017. All patients received NPWT after surgery before attempting DPC. The extent of peritonitis was categorized according to Hinchey's classification. Patients in stages II-IV were included. Results: Five patients had surgical site infections (SSIs) during NPWT and did not receive a DPC (9%). Of the 51 patients that received DPCs, 44 had no infection (91%) and 7 developed SSIs after the DPC (13.7%). For stages II, III, and IV, the SSI rates were 0%, 22.6%, and 35.7%, respectively; the median (range) times to wound healing were 15 (10-36), 19 (11-99), and 19 (10-53) days, respectively. There were no significant differences between the stages. Conclusions: NPWT followed by DPC resulted in low infection rates in each peritonitis stage. This approach appears promising as an alternative to traditional DPC alone for treating lower gastrointestinal perforations.
Collapse
Affiliation(s)
- Hirofumi Ota
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Digestive Surgery, Ikeda City Hospital, Ikeda, Japan
| | - Katsuki Danno
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Minoh City Hospital, Minoh, Japan
| | - Katsuya Ohta
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan
| | - Tae Matsumura
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Osaka Rosai Hospital, Sakai, Japan
| | - Takamichi Komori
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Osaka General Medical Center, Osaka, Japan
| | - Shu Okamura
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Suita Municipal Hospital, Suita, Japan
| | - Miho Okano
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Kaizuka City Hospital, Kaizuka, Japan
| | - Atsuhiro Ogawa
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Tane General Hospital, Osaka, Japan
| | - Hiroshi Tamagawa
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Otemae Hospital, Osaka, Japan
| | - Mamoru Uemura
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Chu Matsuda
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Tsunekazu Mizushima
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Hirofumi Yamamoto
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Riichiro Nezu
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Surgery, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
| | - Yuichiro Doki
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Hidetoshi Eguchi
- The Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).,Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| |
Collapse
|